Case Note & Summary
The dispute involved two appeals concerning the classification of products manufactured by M/s. Naturalle Health Products (P) Ltd. under the Central Excise and Salt Act, 1944. The first appeal questioned whether medicated cough drops and throat drops were classifiable as Ayurvedic medicaments, while the second appeal focused on the classification of 'Sloan’s Balm' and 'Sloan’s Rub'. The appellants contended that their products were Ayurvedic medicines and should attract nil rate duty under sub-heading 3003.30, whereas the revenue argued for classification under sub-heading 3003.10, which attracted a 15% duty. The appellants had previously filed classification lists and received a loan license to manufacture Ayurvedic drugs. The Assistant Collector initially classified the products as patent or proprietary medicaments, a decision upheld by the Collector of Central Excise and later by the CEGAT. The appellants argued that their products contained Ayurvedic ingredients and were manufactured according to Ayurvedic principles, supported by authoritative texts. The court analyzed the definitions and classifications under the Central Excise Tariff and the Drugs and Cosmetics Act, emphasizing the need for products to be manufactured according to Ayurvedic texts to qualify for classification as Ayurvedic medicines. Ultimately, the court upheld the revenue's classification, determining that the appellants did not meet the necessary criteria for Ayurvedic classification. The decision reinforced the importance of adhering to established definitions and classifications in determining excise duty liabilities.
Headnote
A) Central Excise - Classification of Goods - Ayurvedic Medicaments - Classification of medicated cough drops and throat drops under Central Excise Tariff - Central Excise and Salt Act, 1944, Section 35 L(B) - The court held that the products manufactured by the appellants did not meet the criteria for classification as Ayurvedic medicaments under the relevant tariff heading, as the formulation was not in accordance with Ayurvedic texts. (Paras 1-10). B) Central Excise - Burden of Proof - Onus of classification - Central Excise and Salt Act, 1944 - The court emphasized that the burden of proving that a product qualifies for a specific tariff classification lies with the revenue, and the appellants provided sufficient evidence to support their claim for classification as Ayurvedic medicines. (Paras 11-20).
Issue of Consideration
Whether medicated cough drops and throat drops are classifiable as Ayurvedic Medicaments for central excise duty.
Final Decision
The Supreme Court upheld the classification of the products as patent or proprietary medicaments under sub-heading 3003.10, rejecting the appellants' claim for classification as Ayurvedic medicines under sub-heading 3003.30. The court emphasized the need for adherence to Ayurvedic texts in manufacturing to qualify for Ayurvedic classification.
Law Points
- Classification of goods
- Central Excise duty
- Ayurvedic medicines
- Drugs and Cosmetics Act
- 1940
- Central Excise and Salt Act
- 1944
